CODX vs SCHW · rev $3.9M vs P/E 19, rev $23.92B
Co-Diagnostics, Inc. Common Stock (CODX) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SCHW revenue for 2025-12-31 was $23.92B. Net income was $8.85B. Revenue was up 22.0% from 2024-12-31 to 2025-12-31. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
CODX currently screens at market cap $31.4M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the CODX and SCHW stock pages for the full models.
Not investment advice.